Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sitagliptin (januvia) (1 trial)
darolutamide (Nubeqa) (1 trial)
degarelix acetate (firmagon) (1 trial)
docetaxel (taxotere) (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
atorvastatin (lipitor) (1 trial)
dutasteride (avodart) (1 trial)
fluorocholine (1 trial)
pravastatin (pravachol) (1 trial)
rosuvastatin (crestor) (1 trial)
simvastatin (zocor) (1 trial)
Metabolic Syndrome (Phase 3)
Prostatic Neoplasms (Phase 3)
Syndrome (Phase 3)
Trials (6 total)
Trial APIs (12 total)